Renaissance Technologies’s Cocrystal Pharma COCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$186K Sell
125,028
-600
-0.5% -$894 ﹤0.01% 3186
2025
Q1
$178K Sell
125,628
-200
-0.2% -$284 ﹤0.01% 3097
2024
Q4
$254K Sell
125,828
-4,200
-3% -$8.48K ﹤0.01% 3090
2024
Q3
$229K Buy
130,028
+200
+0.2% +$352 ﹤0.01% 3079
2024
Q2
$302K Buy
129,828
+3,800
+3% +$8.85K ﹤0.01% 2903
2024
Q1
$176K Buy
126,028
+900
+0.7% +$1.26K ﹤0.01% 3253
2023
Q4
$215K Sell
125,128
-1,100
-0.9% -$1.89K ﹤0.01% 3110
2023
Q3
$236K Buy
126,228
+1,700
+1% +$3.18K ﹤0.01% 3032
2023
Q2
$298K Buy
124,528
+4,700
+4% +$11.2K ﹤0.01% 3123
2023
Q1
$238K Buy
119,828
+5,800
+5% +$11.5K ﹤0.01% 3208
2022
Q4
$222K Sell
114,028
-19,674
-15% -$38.3K ﹤0.01% 3370
2022
Q3
$467K Sell
133,702
-8,151
-6% -$28.5K ﹤0.01% 2962
2022
Q2
$698K Sell
141,853
-174
-0.1% -$856 ﹤0.01% 2945
2022
Q1
$937K Sell
142,027
-16,550
-10% -$109K ﹤0.01% 2771
2021
Q4
$1.24M Sell
158,577
-10,320
-6% -$80.5K ﹤0.01% 2495
2021
Q3
$2.13M Sell
168,897
-47,264
-22% -$595K ﹤0.01% 2040
2021
Q2
$3.24M Sell
216,161
-138,412
-39% -$2.08M ﹤0.01% 1918
2021
Q1
$5.91M Buy
354,573
+25,408
+8% +$424K 0.01% 1554
2020
Q4
$5.37M Buy
329,165
+10,467
+3% +$171K 0.01% 1539
2020
Q3
$3.56M Buy
318,698
+62,754
+25% +$700K ﹤0.01% 1774
2020
Q2
$4.67M Buy
255,944
+128,992
+102% +$2.35M ﹤0.01% 1684
2020
Q1
$1.08M Buy
126,952
+116,179
+1,078% +$990K ﹤0.01% 2388
2019
Q4
$64K Buy
10,773
+9,896
+1,128% +$58.8K ﹤0.01% 3369
2019
Q3
$22K Buy
+877
New +$22K ﹤0.01% 3371